• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献 >>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

颅内动脉粥样硬化性狭窄球囊成形术后血管管腔扩张性重构的相关因素分析

Analysis of related factors for vascular luminal dilatational remodeling after balloon angioplasty for intracranial atherosclerotic stenosis

摘要:

目的:探讨影响颅内动脉粥样硬化性狭窄(ICAS)球囊成形术后血管管腔扩张性重构(VLDR)的相关因素。方法:研究采用病例对照方法,分析2019年1月至2022年1月河南省人民医院接受单纯紫杉醇涂层球囊血管成形术(PCBA)或普通球囊血管成形术(POBA)治疗并且完成术后半年随访的症状性ICAS患者,按照随访DSA是否发生VLDR分为VLDR组和非VLDR组,收集患者的基线资料、术前和术后病变特征(DSA)及围手术期相关资料。VLDR定义为在动脉粥样硬化性狭窄患者血管内介入成形术后的影像随访中,病变部位管腔最狭窄处的狭窄率相较于术后即刻狭窄率减少大于10%。采用多因素logistic回归对球囊类型、球囊长度、扩张时间等可能影响VLDR的相关因素进行分析。结果:本研究共纳入88例患者,其中VLDR组16例,非VLDR组72例,所有纳入研究的患者随访时间为6.00(5.00,7.00)个月。有18.2%(16/88)病例出现VLDR,PCBA后VLDR发生率为30.4%(14/46),POBA后发生率为4.8%(2/42)。单因素logistic回归分析显示球囊类型、球囊长度、扩张时间、术后即刻狭窄率、随访时间和Mori分型可能会对VLDR发生产生影响,多因素logistic回归分析显示紫杉醇涂层球囊(PCB)的使用( OR=9.82,95% CI 1.99~48.49, P=0.005)和术后即刻狭窄率( OR=1.07,95% CI 1.00~1.14, P=0.042)是VLDR的独立影响因素。 结论:ICAS球囊血管成形术后VLDR与PCB的使用和术后即刻狭窄率相关,这将对临床中PCB应用提供一定的指导价值。

更多
abstracts:

Objective:To explore the factors associated with vascular luminal dilatational remodeling (VLDR) following balloon angioplasty for intracranial atherosclerotic stenosis (ICAS).Methods:A case-control study was conducted to analyze the data of symptomatic severe ICAS patients who received either paclitaxel-coated balloon angioplasty (PCBA) or plain balloon angioplasty (POBA) at our center from January 2019 to January 2022 and completed the six-month follow-up. The patients were divided into VLDR group and non-VLDR group according to whether VLDR occurred on follow-up digital subtraction angiography (DSA). The baseline data, preoperative and postoperative lesion characteristics (DSA), and perioperative related information were collected. The definition of VLDR was a decrease in luminal stenosis rate by more than 10% at the time of follow-up compared to the immediate postoperative period. Multivariate logistic regression was performed to analyze possible factors affecting VLDR such as balloon type, balloon length, and expansion time.Results:A total of 88 patients were included in this study, with 16 in the VLDR group and 72 in the non-VLDR group. The follow-up time for all included patients was 6.00 (5.00, 7.00) months. VLDR occurred in 18.2% (16/88) of cases, with a VLDR incidence of 30.4% (14/46) after PCBA and 4.8% (2/42) after POBA. Univariate logistic regression analysis revealed that treatment balloon type, balloon length, inflated time, immediate postoperative stenosis rate, follow-up time and Mori classification may affect the occurrence of VLDR. Multivariate logistic regression analysis showed that the use of paclitaxel-coated balloon (PCB) ( OR=9.82, 95% CI 1.99-48.49, P=0.005) and postoperative immediate stenosis rate ( OR=1.07, 95% CI 1.00-1.14, P=0.042) were independently associated with VLDR. Conclusion:The occurrence of VLDR following balloon angioplasty in ICAS was associated with the use of PCB and immediate postoperative stenosis rates, which will provide guidance for the clinical application of PCB.

More
作者: 丁乾昊 [1] 贺迎坤 [1] 赵婧革 [2] 何艳艳 [1] 刘文波 [1] 唐垚 [1] 郭德华 [1] 周腾飞 [1] 朱良付 [1] 王子亮 [1] 李天晓 [1]
期刊: 《中华放射学杂志》2024年58卷8期 850-858页 MEDLINEISTICPKUCSCD
栏目名称: 介入放射学
DOI: 10.3760/cma.j.cn112149-20230930-00250
发布时间: 2024-09-10
基金项目:
河南省医学科技攻关计划省部共建青年项目 河南省科技攻关项目 国家卫生健康委能力建设和继续教育项目 河南省重点研发专项 Henan Medical Science and Technology Research Plan Provincial and Ministerial Youth Project Henan Province Key Research and Development & Promotion Special (Science and Technology) Foundation National Health Commission Capacity Building and Continuing Education Project Key Research and Development Project of Henan Province
  • 浏览:14
  • 下载:1

加载中!

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

扩展文献

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学网小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学网小程序

使用
帮助
Alternate Text
调查问卷
Baidu
map